Orthofix Reports Fourth Quarter and Full-Year 2024 Results and Provides 2025 Financial Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St rises on AI gains as oil slides, Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips briefly below $100 on Saudi exports, hopes of US-Iran diplomacy
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- AMD stock jumps as chip rally builds ahead of summit
BTIG Reiterates Neutral Rating on Orthofix International (OFIX)
February 25, 2025 1:01 PM ESTBTIG analyst Ryan Zimmerman reiterated a Neutral rating on Orthofix International (NASDAQ: OFIX).
The analyst comments "We maintain our Neutral following 4Q24 results. OFIX reported rev. of $215.7M (7.6% Y/Y, 7.8% xFx) above Cons. at $212.7M while adj. EBITDA of $23.9M beat Street ests. of $22.6M. Growth was driven by Global Orthopedics (18.1% Y/Y xFx) and BGT (8.6% Y/Y).... More
